Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17808299 | 0.86 | ALDH1A1 (0.58) | SMN1; SMN2L3MBTL1ALDH1A1KDM4EKMT2A | |
| SCHEMBL16455682 | 0.83 | POLB (0.56) | SMN1; SMN2L3MBTL1POLBALDH1A1KDM4E | |
| SCHEMBL23833576 | 0.75 | KDM4E (0.55) | SMN1; SMN2L3MBTL1POLBALDH1A1KDM4E | |
| SCHEMBL22601463 | 0.75 | LMNA (0.56) | SMN1; SMN2L3MBTL1POLBALDH1A1KDM4E | |
| SCHEMBL25364077 | 0.71 | POLB (0.35) | SMN1; SMN2L3MBTL1POLBALDH1A1TDP1 | |
| SCHEMBL2705569 | 0.71 | SMN1; SMN2 (0.85) | SMN1; SMN2L3MBTL1POLBALDH1A1MEN1 | |
| SCHEMBL15872007 | 0.70 | ALDH1A1 (0.71) | SMN1; SMN2L3MBTL1POLBALDH1A1TDP1 | |
| SCHEMBL4555634 | 0.70 | ALDH1A1 (0.71) | SMN1; SMN2L3MBTL1POLBALDH1A1TDP1 | |
| SCHEMBL13468624 | 0.70 | SMN1; SMN2 (0.62) | SMN1; SMN2L3MBTL1POLBALDH1A1MEN1 | |
| SCHEMBL14200105 | 0.70 | ALDH1A1 (0.65) | SMN1; SMN2L3MBTL1POLBALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9611248-B2 | Chemical compounds | SYNGENTA LIMITED (GB) | 2017-04-04 | — | — | US | disclosed |
| US-9611248-B2 | Chemical compounds | SYNGENTA LIMITED (GB) | 2017-04-04 | — | — | US | disclosed |
| US-20160159767-A1 | CHEMICAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159767-A1 | CHEMICAL COMPOUNDS | DDT, CBR3, CYP1B1 | SMN1; SMN2 4478/4885L3MBTL1 1725/4885POLB 1307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.